Medical Economics Newsletter

To view this email as a web page, click here.

Seven most out-of-reach drugs for patients due to high costs

Drug costs are increasing, but so is patient cost sharing. That's raising serious problems for some patients (from our partners at Managed Healthcare Executive).

View the slideshow

Poll: What's ruining medicine for physicians?

Doctors face many challenges that interfere with running a practice and caring for patients. Tell us what issues you think are ruining medicine.

Take the poll

Hepatitis C virus eradication by direct-acting antiviral agents improves glucose tolerance

Glucose tolerance is an independent predictor of overall mortality and hepatic decompensation in patients with HCV cirrhosis.

Learn more

FROM OUR LATEST ISSUE

Check out our latest issue, featuring:

• Why facility fees are a farce
• A guide to malpractice insurance
• How to sell your practice

In spite of favorable legal and regulatory conditions, physician shortages persist.

This whitepaper answers common questions from doctors

Popular online this week

Hydrocarbon regulations bring sustainability to physicians' practices

Bringing value-based compensation to your medical practice

The tech-savvy way of running the modern private practice

Physician burnout is real. Here’s how to fix it.

Find out how tools, resources, and latitude can give physicians the support they need. Read More

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.